Keywords

• PF-07321332
• Paxlovid factory
• Paxlovid supplier

Quick Details

• ProName: Paxlovid
• CasNo: 2628280-40-8
• Molecular Formula: C23H32F3N5O4
• Appearance: powder
• Application: PF-07321332 (nirmatrelvir) is an oral ...
• DeliveryTime: Delivery within one week after order c...
• PackAge: aluminum foil bag, drum, carton, or pa...
• Port: Tianjin,Qingdao, Shanghai, Shenzhen
• ProductionCapacity: 100 Kilogram/Day
• Purity: 99%
• Storage: Store at -20°C
• Transportation: by express, by air, by sea
• LimitNum: 1 Gram

Superiority

Factory direct sales, accept customization.

PF-07321332 (nirmatrelvir) is an oral antiviral clinical lead. It is a covalent inhibitor of SARS-CoV-2 Mpro (main protease, 3CLpro) that binds to cysteine145 within the enzyme's catalytic domain. Mpro is essential for coronavirus replication. Inhibiting Mpro actvity blocks replication at an early stage in the virus' life cycle. Due to structural similarities between the Mpro's of other coronavirusus, PF-07321332 offers the potential of pan-coronavirus activity. In vitro it is suggested to inhibit replication of CoV-2 variants including delta and omicron.

Kind Pharma has its own laboratory, we can do analytical testing for API (Active Pharmaceutical Ingredient), pharmaceutical intermediate, pesticide intermediate, additive and other chemical products, so it can make sure Quality Assurance.

Professional Staff
Our laboratory department is run by our highly skilled QC team consists of analytical chemists and laboratory technicians. We can ensure that our company can provide you professional and efficient service.

Professional Equipments and Instruments
Our advanced laboratory is furnished with all the necessary equipments and instruments to process the analysis of substances. Including HPLC,GC,Moisture Analyzer, Melting Point Meter, Polarimeter, UV Spectrophotometer, Drying Oven, Muffle Furnace, etc.
We are able to analyze the purity, content, gas phase, melting point, specific rotation, UV, weight loss, burning residue and titration of API and Intermediate.

Quality Police
We have already introduced advanced analytical instruments to evaluate the quality of API/Intermediate, set API/Intermediate specifications and testing methods. Our analytical laboratory is constantly being updated to meet pharmaceutical industry standards and customer expectations. we are determined to continuously contribute to the growth of the pharmaceutical industry and support people for their healthier lives.

Details

PF-07321332 (nirmatrelvir) is an oral antiviral clinical lead. It is a covalent inhibitor of SARS-CoV-2 Mpro (main protease, 3CLpro) that binds to cysteine145 within the enzyme's catalytic domain. Mpro is essential for coronavirus replication. Inhibiting Mpro actvity blocks replication at an early stage in the virus' life cycle. Due to structural similarities between the Mpro's of other coronavirusus, PF-07321332 offers the potential of pan-coronavirus activity. In vitro it is suggested to inhibit replication of CoV-2 variants including delta and omicron.

Tianjin Kind Pharma Co., Ltd., founded in 2013, which is located in Wuqing Development Zone, Tianjin, China, and it is convenient for transportation. We are a professional manufacturer and exporter specializing in API (Active Pharmaceutical Ingredient), Pharmaceutical Intermediate, Pesticide Intermediate, Additive and other chemical products. Our company insists on quality-driven development, continuously improving the level of enterprise management and strengthening the awareness of quality control and risk management, we have played an important role in promoting the innovation and development of Chinese pharmaceutical industry.

Our company has first-class technical personnel, senior R&D team, advanced production equipment, efficient, compliant, flexible production capacity and quality management capability, sound Q.A. System and testing method, perfect marketing network, excellent logistics distribution, and quick response after-sales service. Our products are produced in strict accordance with GMP requirements, in line with international standards. In addition, we can also provide Contract Development Manufacture Organization (CDMO) services according to customer’s requirement. At present, our company has established long-term and stable strategic partnership with many internationally renowned pharmaceutical companies, and we have been recognized by many domestic and international drug regulatory agencies. Our products have received unanimous praise from customers in the Europe, North America, South America, South Korea, New Zealand, and Southeast Asia.

We adhere to the principle of "Technological Innovation, Service First" and customer-oriented, providing customers with one-stop and personalized solutions and professional and reliable services. Warmly welcome friends to visit and cooperate from all over the world.

Vision: To be the world's leading Contract Development Manufacture Organization (CDMO) enterprise and international trade platform for the pharmaceutical industry.

Mission: To provide customers with the best customized services and one-stop solutions, enhance customer satisfaction with our company, and promote innovation and development in the global pharmaceutical industry.